CO-Trimoxazole

Base Information

• Chemical Name: CO-Trimoxazole
• CAS No.: 8064-90-2
• Deprecated CAS: 74711-00-5,117385-88-3,37341-72-3,38916-35-7,50641-67-3,50808-41-8,52499-85-1,8064-91-3,8076-73-1,117385-88-3,37341-72-3,38916-35-7,39422-07-6,50641-67-3,50808-41-8,52499-85-1,8064-91-3,8064-92-4,8076-73-1
• Molecular Formula: C14H18N4O3•C10H11N3O3S
• Molecular Weight: 543.66
• NSC Number: 618652
• DSSTox Substance ID: DTXSID0032233
• Wikipedia: Trimethoprim/sulfamethoxazole
• Wikidata: Q898623
• NCI Thesaurus Code: C909
• ChEMBL ID: CHEMBL58061
• Mol file: 8064-90-2.mol

Synonyms:Abactrim;Bactifor;Bactrim;Biseptol;Biseptol 480;Biseptol-480;Biseptol480;Centran;Centrin;Co Trimoxazole;Co-Trimoxazole;Cotrimoxazole;Drylin;Eslectin;Eusaprim;Insozalin;Kepinol;Kepinol Forte;Lescot;Metomide;Oriprim;Septra;Septrin;Sulfamethoxazole Trimethoprim Combination;Sulfamethoxazole-Trimethoprim Combination;Sulprim;Sumetrolim;TMP SMX;TMP-SMX;Trimedin;Trimethoprim Sulfamethoxazole;Trimethoprim Sulfamethoxazole Combination;Trimethoprim, Sulfamethoxazole Drug Combination;Trimethoprim-Sulfamethoxazole;Trimethoprim-Sulfamethoxazole Combination;Trimethoprimsulfa;Trimezole;Trimosulfa

Chemical Property of CO-Trimoxazole

Chemical Property:

• Vapor Pressure: 3.74E-11mmHg at 25°C
• Boiling Point: 526°C at 760 mmHg
• Flash Point: 271.9°C
• PSA: 212.11000
• LogP: 5.52100
• Storage Temp.: ?20°C
• Hydrogen Bond Donor Count: 4
• Hydrogen Bond Acceptor Count: 13
• Rotatable Bond Count: 8
• Exact Mass: 543.19000284
• Heavy Atom Count: 38
• Complexity: 653

Purity/Quality:

99%, ^*data from raw suppliers

Cotrimoxazole ^*data from reagent suppliers

Safty Information:

• Hazard Codes: Xi
• Statements: 36/37/38-43
• Safety Statements: 26-36/37

MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:

• Canonical SMILES: CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N.COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
• Recent ClinicalTrials: Effects of Treatments on Atopic Dermatitis
• Recent EU Clinical Trials: Evaluation of the efficacy of treatment with mucosal bacterial vaccines (autovaccines) versus suppressive antibiotic treatment in subjects with hip or knee prosthesis infections.
• Uses: Cotrimoxazole is an antibiotic. Pseudomonas aeruginosa has a drug resistant rate of 66% in the years 2010-2013.